Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: Significance in the elderly

Current Psychiatry Reports

Volumn 5, Issue 5, 2003, Pages 384-390

  Davis, Jennifer Duncan ^a   Stern, Robert A ^b   Flashman, Laura A ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CYTOKINE; IODINE; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROTIRELIN; RADIOACTIVE IODINE; THYROID HORMONE; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADENOHYPOPHYSIS; AGED; AGING; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DATA ANALYSIS; DEGENERATIVE DISEASE; DEMENTIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRY SKIN; FATIGUE; GERIATRIC CARE; GRAVES DISEASE; HASHIMOTO DISEASE; HORMONE METABOLISM; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; IRRADIATION; MENTAL DISEASE; MUSCLE CRAMP; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; PARESTHESIA; PATIENT MONITORING; PREVALENCE; REVIEW; RISK FACTOR; SCREENING TEST; SYMPTOMATOLOGY; THYROID DISEASE; THYROID GLAND; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; WEIGHT GAIN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METHODOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; THYROID FUNCTION TEST;

AGED; CLINICAL TRIALS; COGNITION DISORDERS; DEMENTIA; DEPRESSIVE DISORDER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; PITUITARY-ADRENAL SYSTEM; RISK FACTORS; THYROID FUNCTION TESTS; THYROXINE;

EID: 0642336294     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-003-0073-6     Document Type: Review

References (48)

1. Stern RA, Prange AJ Jr: Neuropsychiatric aspects of endocrine disorders. In Comprehensive Textbook of Psychiatry, vol 6. Edited by Kaplan HI, Sadock BJ. Baltimore: Williams and Wilkins; 1995:241-251.
2. Cooper DS: Subclinical hypothyroidism. N Engl J Med 2001, 345:260-265.
3. Canaris GJ, Manowitz NR, Maycor G, Ridgeway EC: The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160:526-534.
4. Staub JJ, Althaus BU, Engler H, et al.: Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992, 92:631-642.
5. Sawin CT, Geller A, Wolf PA, et al.: Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994, 31:1249-1252.
6. Hak AE, Pols HAP, Visser TJ, et al.: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000, 132:270-278.
7. Prinz PN, Scanlan JM, Vitaliano PP, et al.: Thyroid hormones positive relationships with cognition in healthy, euthyroid, older men. J Gerontol A Biol Sci Med Sci 1999, 54:M111-M116.
8. Wahlin A, Wahlin TB, Small BJ, et al.: Influences of thyroid stimulating hormone on cognitive functioning in very old age. J Gerontol B Psychol Sci Soc Sci 1998, 53:234-239.
9. Volpato S, Guralnik JM, Fried LP, et al.: Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 2002, 58:1055-1061.
10. Ganguli M, Burmeister LA, Seaberg EC, et al.: Association between dementia and elevated TSH: a community-based study. Biol Psychiatry 1996, 40:714-725.
11. Kvetny J: Nuclear thyroxine and triiodothyronine binding in mononuclear cells independent of age. Horm Metab Res 1985, 17:35-38.
12. Mariotti S, Franceschi C, Cossarizza A, Pinchera A: The aging thyroid. Endocr Rev 1995, 16:686-715.
13. Tunbridge WMG, Evered DC, Hall R, et al.: The spectrum of thyroid disease in the community: the Whickham Survey. Clin Endocrinol 1977, 7:481-493.
14. Olsen T, Laurbert P, Weeke J: Low serum triiodothyronine and high serum reverse triiodothyronine in old age: an effect of disease not age. J Clin Endocrinol Metab 1978, 47:1111-1115.
15. Evered DC, Ormston BJ, Smith PA, et al.: Grades of hypothyroidism. Br Med J 1973, 1:290-293.
16. Wenzel KW, Meinhold H, Raffenberg M, et al.: Classification of hypothyroidism in evaluating patients after radioiodine therapy by serum cholesterol, T3 uptake, total T4, F-T4, Total T3, basal TSH, and TRH test. Eur J Clin Invest 1974, 4:141-148.
17. Marocchi C, Chiovato L: Thyroid-directed antibodies. In Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text, edn 8. Edited by Braverman LE, Utiger RD. Philadelphia: Lippincott Williams & Wilkins; 2000:406-415.
18. Sawin CT, Chopra D, Azizi F, et al.: The aging thyroid: increased prevalence of serum thyrotropin levels in the elderly. J Am Med Assoc 1979, 242:247-250.
19. Sawin CT, Castelli WP, Hershman JM, et al.: The aging thyroid: thyroid deficiency in the Framingham Study. Arch Intern Med 1985, 145:1386-1388.
20. Vanderpump MPJ, Tunbridge WMG, French JM, et al.: The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995, 43:55-68.
21. Hawkins BR, Dawkins RL, Burger HG, et al.: Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet 1980, 2:1057-1059.
22. Manicet G, Dartigues JF, Decamps A, et al.: The PAQUID survey and correlates of subclinical hypothyroidism in elderly community residents in the southwest of France. Age Ageing 1995, 24:235-241.
23. Sundbeck G, Eden S, Jagenburg R, et al.: Prevalence of serum antithyroid peroxidase antibodies in 85-year old women and men. Clin Chem 1995, 41:707-712.
24. Pinchera A, Mariotti S, Barbesino G, et al.: Thyroid autoimmunity and aging. Horm Res 1995, 43:64-68.
25. Mokshagundam S, Barzel US: Thryoid disease in the elderly. J Am Geriatr Soc 1993, 1361-1369.
26. Koh LKH, Greenspan FS, Yeo PPB: Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid 1997, 7:891-896.
27. Cooper DS, Halpern R, Wood LC, et al.: L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984, 101:18-24.
28. Samuels MH: Subclinical thyroid disease in the elderly. Thyroid 1998, 8:803-813.
29. Doucet J, Trivalle CH, Chassagne PH, et al.: Does age play a role in the clinical presentation of hypothyroidism? J Am Geriatr Soc 1994, 42:984-986.
30. Baldini M, Vita A, Mauri MC, et al.: Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:925-935.
31. Monzani F, Del Guerra P, Caraccio N, et al.: Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Invest 1993, 71:367-371.
32. del Ser Quijano T, Delgado C, Martinez Espinosa S, Vazquez C: Cognitive deficiency in mild hypothyroidism. Neurologia 2000, 15:193-198.
33. Osterweil D, Syndulko K, Cohen SN, et al.: Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 1992, 40:325-335.
34. Haggerty JJ, Stern RA, Mason GA, et al.: Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry 1993, 150:508-510.
35. Joffe RT, Levitt AJ: Major depression and subclinical hypothyroidism. Psychoendocrinology 1992, 17:215-221.
36. Tappy L, Randin J, Schwed P, et al.: Prevalence of thyroid disorders in psychogeriatric inpatients: a possible relationship of hypothyroidism with neurotic depression but not with dementia. J Am Geriatr Soc 1987, 35:526-531.
37. Jackson IM: The thyroid axis and depression. Thyroid 1998, 8:951-956.
38. Esposito SM, Haggerty JJ, Stern RA, et al.: Geropsychiatric effects of subclinical hypothyroidism. Paper presented at the 147th Annual Meting of the American Psychiatric Association. Philadelphia, PA; May 1994.
39. Nyström E, Caidahl K, Fager G, et al.: A double-blind crossover 12-month study of L-thyroxine treatment of women with "subclinical" hypothryoidism. Clin Endocrinol 1988, 29:63-76.
40. Jaeschke R, Guyatt G, Gerstein H, et al.: Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996, 11:744-749.
41. Meier C, Staub JJ, Roth CB, et al.: TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001, 86:4860-4866.
42. Kong WM, Sheikh MH, Lumb PJ, et al.: A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidsim. Am J Med 2002, 112:348-354.
43. Trzepacz PT, McCue M, Klein I, et al.: Psychiatric and neuropsychological response to propanolol in Graves' disease. Biol Psychiatry 1988, 23:678-688.
44. Davis JD, Stern RA: A case of apparent progressive cognitive decline in an older woman with multiple treated endocrinopathies: importance of considering endocrine status in diagnosing dementia [abstract]. J Neuropsychiatry Clin Neurosci 2003, 15:268.
45. Monguilod MJM, Lopez-Fraile IP: Subclinical hypothyroidism as a cause of reversible cognitive deterioration. Neurologia 1996, 11:353-356.
46. Stern RA, Robinson B, Thorner AR, et al.: A survey study of neuropsychiatric complaints in patients with Graves' disease. J Neuropsychiatry Clin Neurosci 1996, 8:181-185.
47. Stern RA, Davis JD, Rogers BL, et al.: A double-blind study of thyroxine in the treatment of Alzheimer's dementia [abstract]. J Neuropsychiatry Clin Neurosci 2003, 15:272.
48. Ladenson PW, Singer PA, Ain KB, et al.: American thyroid association guidelines of detection of thyroid dysfunction. Arch Intern Med 2000, 160:1573-1575.